Company Updates
Cure Brain Cancer introduces SW/TCH Australia
Cure Brain Cancer is excited to introduce SWITCH, an event which will bring young entrepreneurs, starts-ups, and ASX corporations together to solve big business challenges, while supporting brain cancer research. Cure Brain Cancer is doing things differently to solve the complex problem of brain cancer and this week we are excited to announce another innovative […]
Crowd Mobile appoints new Chairman and launches services into Italy and Hungary
Source: ASX Q Limited (ASX:QXQ) has been advised by Crowd Mobile Group that is has appointed technology and media expert Theo Hnarakis as its Non-executive Chairman. Mr Hnarakis has held senior roles with News Corporation, Boral Group, the PMP Communications group and most recently was the Managing Director and CEO of Melbourne IT. Q Limited […]
PharmAust Ltd – Human Cancer Trial Advancing to Second Patient
ASX Release – Tuesday 21 October 2014 PharmAust Limited (ASX; PAA & PAAO) is pleased to report that it is now advancing to the treatment of the second patient in its “First in Man” trial with PPL-1. Following the approval of the study by the Royal Adelaide Hospital research Ethics Committee in April 2014, the […]
Qanda Technology Ltd signs Strategic Agreement with McMillan Shakespeare Group
ASX Announcement – Thursday 23 October 2014 DriveMyCar Rentals signs strategic agreement with McMillan Shakespeare Group Strategic agreement signed with Interleasing, a wholly owned subsidiary of McMillan Shakespeare Limited Significantly increases supply of vehicles and sales potential across Australia Provides Interleasing with our new revenue stream and extended asset life Demonstrates potential for peer to […]
Dimerix Bioscience develop DMX200 to improve the outcome of Chronic Kidney Disease
23 October 2014 – Dimerix Bioscience Limited DMX200 – the first therapy from the extensive pipeline of potential new treatments from Dimerix Bioscience Chronic kidney disease has a high rate of premature death. It has been identified as the seventh most common cause (underlying or associated) of death in Australia. The growth in kidney […]
Leaf Resources Research Report
Leaf Resources (ASX:LER) owns the IP for a new pre-treatment process to extract cellulose from biomass. It is a disruptive technology with the potential to reshape the economics of using large scale renewable biomass as a feedstock (and an alternative to oil) into the chemicals, plastics and downstream industries; fast growing, billion dollar industries. Leaf […]
NTA discounts invoices and disclosure
Source; Banking Day, 17 October 2014 Fringe lenders, often new suppliers, are climbing out of the detritus of the GFC and adding to the supply of credit in the Australian economy. One newcomer is NTA Securities, a Sydney-based firm that will provide working capital and debt finance secured against invoices, a business lending niche under-served […]
Leaf Resources enters Collaboration Agreement with ZeaChem Inc
ASX Announcement; 16 October 2014 The Directors of Leaf Resources are pleased to announce the signing of a Collaboration Agreements with ZeaCheam Inc. of Lakewood, Colarado. The agreement covers the evaluation of ZeaCheam and Leaf Resources of the Leaf Glycell process for the production of fermentable sugars at ZeaChem’s demonstration plant at Boardman, Oregon. The […]
Works Commence on Gold Coast Indoor Skydive facility
ASX / Media Release- Monday 20 October 2014 iFly Gold Coast – Works Commence Indoor Skydive Australia Group Limited (ASX:IDZ) (ISA Group) is pleased to announce that work has commenced on the iFly Gold Coast indoor skydiving facility at 3082 and 3084 Surfers Paradise Boulevard, Surefrs Paradise. On 27 August 2014 ISA Group received approval […]
Backed By Leading Investment Groups and Family Offices
